Viewing Study NCT04596293


Ignite Creation Date: 2025-12-25 @ 1:00 AM
Ignite Modification Date: 2025-12-26 @ 1:33 PM
Study NCT ID: NCT04596293
Status: COMPLETED
Last Update Posted: 2023-09-07
First Post: 2020-10-15
Is NOT Gene Therapy: True
Has Adverse Events: True

Brief Title: Efficacy and Safety of Orally Administered BBT-401-1S in Subjects With Ulcerative Colitis
Sponsor: Bridge Biotherapeutics, Inc.
Organization:

Key Dates - Follows AllAPIJSON File Order

Start Date: 2021-06-11
Start Date Type: ACTUAL
Primary Completion Date: 2022-05-17
Primary Completion Date Type: ACTUAL
Completion Date: 2022-07-12
Completion Date Type: ACTUAL
First Submit Date: 2020-10-15
First Submit QC Date: None
Study First Post Date: 2020-10-22
Study First Post Date Type: ACTUAL
Results First Submit Date: 2023-06-16
Results First Submit QC Date: None
Results First Post Date: 2023-09-07
Results First Post Date Type: ACTUAL
Results First Post QC Date: None
Results First Post QC Date Type: None
Disp First Submit Date: None
Disp First Submit QC Date: None
Disp First Post Date: None
Disp First Post Date Type: None
Last Update Submit Date: 2023-08-16
Last Update Post Date: 2023-09-07
Last Update Post Date Type: ACTUAL